Drug information: antiparkinson agents. I. Anticholinergic agents
Veje, V.O.
Sygeplejersken 81(34): 11
1981
ISSN/ISBN: 0106-8350 PMID: 6913222 Document Number: 175788
Document emailed within 1 workday
Related Documents
Veje, J.O. 1981: Drug information: antiparkinson agents Sygeplejersken 81(32): 10Gjerden, P.; Slørdal, L. 1998: Clinical pharmacology of anticholinergic antiparkinson agents. a review with emphasis on acute toxicity Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 118(1): 53-55
Lumholtz, I.B. 1977: Drug information: agents in the treatment of neoplastic diseases. Therapeutic main group: cytostatic agents. 1 Sygeplejersken 77(16): 13
Lumholtz, I.B. 1980: Drug information: agents for the treatment of arrhythmias. Therapeutic main group: anti-arrhythmia agents. 14. Digitalis glycosides Sygeplejersken 80(50): 13
Lumholtz, I.B. 1981: Drug information: agents for the treatment of arrhythmias. Therapeutic main group: anti-arrhythmia agents. 16. (3). Anti-arrhythmia agents with action on ventricular arrhythmias Sygeplejersken 81(2): 15
Ulmer, W.T.; Dorsch, J.; Iravani, J.; Schüler, K.G.; Stempel, G.; Vastag, E. 1973: Anticholinergic agents as bronchodilator agents. Significance of acetylcholine as a bronchoconstrictor transmitter agent in airway obstruction Arzneimittel-Forschung 23(3): 468-476
Estler, C.J. 1984: Drug interactions of central nervous system active drugs. 3: Drug interactions of anticonvulsants and antiparkinson agents Fortschritte der Medizin 102(6): 129-132
Horsmans, Y.; Larrey, D.; Pessayre, D.; Benhamou, J.P. 1990: Hepatotoxicity of antimicrobial agents. II: Urinary antiseptics, antitubercular agents, antiparasitic agents, antifungal agents, antiviral agents Gastroenterologie Clinique et Biologique 14(12): 919-924
Lumholtz, I.B. 1980: Drug information. Therapeutic main group: agents for the treatment of angina pectoris. 10th and last part. 4. other angina pectoris agents Sygeplejersken 80(20): 23
Staal-Schreinemachers, A.L.; Lakke, J.P. 1987: Antiparkinson agents Nederlands Tijdschrift Voor Geneeskunde 131(6): 228-230
Delwaide, P.J. 1996: L-dopa and antiparkinson agents Revue Medicale de Liege 51(1): 61-64
Kurako, I.L.; Volianskiĭ, V.E.; Fadeev, S.M. 1981: Therapeutic effectiveness of modern antiparkinson agents Vrachebnoe Delo 2: 7-11
Fabricius, A. 1984: Drug information. Agents against ulcer diseases Sygeplejersken 84(21): 14
Lumholtz, I.B. 1980: Drug information: agents for the treatment of cardiac arrhythmias. 1 Sygeplejersken 80(22): 26
Occelli, E.; Fontanella, L.; Testa, E. 1977: Bicyclic analogs of piperazine. XII. (1) - Synthesis of 3,8-diazabicyclo/3,2,1/octanes as potential antiparkinson agents Il Farmaco; Edizione Scientifica 32(4): 237-247
Lumholtz, I.B. 1979: Drug information: agents for the treatment of virus infections. Idoxuridine (Iduridin) Sygeplejersken 79(22): 25
Hammer, R.H.; Amin, K.; Gunes, Z.E.; Brouillette, G.; Bodor, N. 1988: Novel 'soft' anticholinergic agents Drug Design and Delivery 2(3): 207-219
Lumholtz, I.B. 1976: Drug information for nurses. Therapeutic main group: expectorants (mucous dissolving agents). 1 Sygeplejersken 76(44): 11
Ziment, I.; Au, J.P. 1986: Respiratory pharmacology. Anticholinergic agents Clinics in Chest Medicine 7(3): 355-366
Spiro, T.; Liu, L.; Gerson, S. 2000: New cytotoxic agents for the treatment of metastatic malignant melanoma: temozolomide and related alkylating agents in combination with guanine analogues to abrogate drug resistance Forum 10(3): 274-285